Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rania Gourgioti"'
Autor:
Dimos D. Mitsikostas, Stylianos Gkatzonis, Maria Maltezou, Dimitrios Papadopoulos, Panayiotis Mitsias, Nikolaos Fakas, Triantafyllos Doskas, Rania Gourgioti
Publikováno v:
Advances in Therapy
Introduction The efficacy of prolonged-release fampridine (PR-FAM) may extend in multiple sclerosis (MS) beyond walking ability. The objective of this study was to evaluate the effect of PR-FAM treatment on cognition, fatigue, depression, and quality
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Background and Objectives For chronic diseases like multiple sclerosis (MS), real-world evidence on long-term treatment outcomes is essential. The study aimed to provide long-term data on the safety and effectiveness of natalizumab in patients with r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::333aa7aa7979f47ee286f4fa7c1bef21
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3030881
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3030881
Autor:
Rania Gourgioti, Antonia Alexopoulou, Panagiotis Karanasios, Georgios Karachalios, Vasileios Mastorodemos
Publikováno v:
Multiple Sclerosis Journal-Experimental, Translational and Clinical
Background Natalizumab is a highly efficacious treatment for relapsing-remitting multiple sclerosis (RRMS). Objective To assess the real-world long-term safety of natalizumab in RRMS. Methods This multicenter, 5-year prospective observational study,